From randomized clinical trials to real life data. An Italian clinical experience with ixekizumab and its management.

類似資料

• When IL-17 inhibitors fail: real-life evidence to switch from secukinumab to adalimumab or ustekinumab.
  著者:: Damiani, Giovanni, 等
  出版事項: (2018)
• Biologics increase the risk of SARS‐CoV‐2 infection and hospitalization, but not ICU admission and death: Real‐life data from a large cohort during red‐zone declaration
  著者:: Damiani, Giovanni, 等
  出版事項: (2020)
• COVID‐19 knowledge prevents biologics discontinuation: Data from an Italian multicenter survey during RED‐ZONE declaration
  著者:: Bragazzi, Nicola Luigi, 等
  出版事項: (2020)
• Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis
  著者:: Damiani, Giovanni, 等
  出版事項: (2019)
• The Impact of Ramadan Fasting on the Reduction of PASI Score, in Moderate-To-Severe Psoriatic Patients: A Real-Life Multicenter Study
  著者:: Damiani, Giovanni, 等
  出版事項: (2019)